News Release
Fourth quarter 2020 net income from continuing operations was
Full year 2020 net loss from continuing operations was
Fourth Quarter Financial Results Highlights
-
Earnings before interest, taxes, depreciation and amortization (“EBITDA”) from ongoing operations for Aluminum Extrusions of
$13.6 million was$0.8 million lower than the fourth quarter of 2019 -
EBITDA from ongoing operations for
PE Films of$11.2 million was$0.5 million higher than the fourth quarter of 2019 -
EBITDA from ongoing operations for
Flexible Packaging Films of$8.1 million was$3.8 million higher than the fourth quarter of 2019
THE IMPACT OF COVID-19
Essential Business and Employee Considerations
The Company’s priorities during the COVID-19 pandemic continue to be to protect the health and safety of employees while keeping its manufacturing sites open due to the essential nature of many of its products. Within the limitations imposed by the health and safety procedures described below, the Company has continued to manufacture the full range of products at its facilities.
The Company’s protocols to protect the health and well-being of its employees from COVID-19 continue to develop as COVID-19 informed work practices evolve and the Company responds to recommended and mandated actions of government and health authorities. In addition, to facilitate a return to fully functional operations, the Company has undertaken an education campaign to provide employees with the most accurate and up-to-date information available, particularly from the
The Company has educated employees about COVID-19, including how the virus is spread, COVID-19 symptoms and mitigation efforts to keep employees safe. Even in those facilities not bound by the Families First Coronavirus Response Act, the Company has adopted COVID-19 related pay and sick leave policies and remote work policies that require employees to stay home if they feel ill or have been exposed to others with the illness, until they are cleared to return to work by our Human Resources team, who applies
Financial Considerations
The 2020 annual plan for
Demand has remained strong under COVID-19 conditions for the Company’s flexible food packaging films produced by Terphane. The Surface Protection component of
Tredegar owns approximately 20% of kaleo, Inc. (“kaléo”), which makes and sells an epinephrine delivery device under the name AUVI-Q®. The Company accounts for its investment in kaléo on a fair value basis. The Company’s estimate of the fair value of its interest in kaléo at
Total debt was
OPERATIONS REVIEW
Aluminum Extrusions
Aluminum Extrusions, which is also referred to as
|
|
Three Months Ended |
|
Favorable/ |
|
Year Ended |
|
Favorable/ |
||||||||||||||
(In thousands, except percentages) |
|
|
|
(Unfavorable) |
|
|
|
(Unfavorable) |
||||||||||||||
|
2020 |
|
2019 |
|
% Change |
|
2020 |
|
2019 |
|
% Change |
|||||||||||
Sales volume (lbs) |
|
46,408 |
|
|
50,102 |
|
|
(7.4 |
)% |
|
186,391 |
|
|
208,249 |
|
|
(10.5 |
)% |
||||
Net sales |
|
$ |
116,145 |
|
|
$ |
124,292 |
|
|
(6.6 |
)% |
|
$ |
455,711 |
|
|
$ |
529,602 |
|
|
(14.0 |
)% |
Ongoing operations: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
EBITDA |
|
$ |
13,641 |
|
|
$ |
14,452 |
|
|
(5.6 |
)% |
|
$ |
55,137 |
|
|
$ |
65,683 |
|
|
(16.1 |
)% |
Depreciation & amortization* |
|
(4,771 |
) |
|
(4,238 |
) |
|
(12.6 |
)% |
|
(17,403 |
) |
|
(16,719 |
) |
|
(4.1 |
)% |
||||
EBIT** |
|
$ |
8,870 |
|
|
$ |
10,214 |
|
|
(13.2 |
)% |
|
$ |
37,734 |
|
|
$ |
48,964 |
|
|
(22.9 |
)% |
Capital expenditures |
|
$ |
5,547 |
|
|
$ |
6,010 |
|
|
|
|
$ |
10,260 |
|
|
$ |
17,855 |
|
|
|
||
* Excludes pre-tax accelerated amortization of trade names of |
Fourth Quarter 2020 Results vs. Fourth Quarter 2019 Results
Net sales (sales less freight) in the fourth quarter of 2020 decreased by 6.6% versus 2019 primarily due to lower sales volume, partially offset by an increase in average selling prices to cover higher operating costs. Metal costs were relatively flat versus the fourth quarter of 2019. Sales volume in the fourth quarter of 2020 decreased by 7.4% versus 2019. Sales volume in the specialty market, which represented 31% of total volume in 2020, increased 9.5% in the fourth quarter of 2020 versus 2019, and sales volume in the automotive market, which represented 9% of total volume in 2020, was relatively flat versus the fourth quarter of 2019. Non-residential sales volume, which represented 55% of 2020 volume, declined 17.5% in the fourth quarter of 2020 versus 2019 primarily as a result of COVID-19-related lower demand. See “The Impact of COVID-19” section for more information on business conditions.
EBITDA from ongoing operations in the fourth quarter of 2020 decreased by
Full Year 2020 Results vs. Full Year 2019 Results
Net sales in 2020 decreased by 14.0% versus 2019 primarily due to lower sales volume and the pass-through of lower metal costs, partially offset by an increase in average selling prices to cover higher operating costs. Sales volume in 2020 decreased by 10.5% versus 2019 with declines in all key markets, which the Company believes was mainly a result of COVID-19-related lower demand.
EBITDA from ongoing operations in 2020 decreased by
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for
|
|
Three Months Ended |
|
Favorable/ |
|
Year Ended |
|
Favorable/ |
||||||||||||||
(In thousands, except percentages) |
|
|
|
(Unfavorable) |
|
|
|
(Unfavorable) |
||||||||||||||
|
2020 |
|
2019 |
|
% Change |
|
2020 |
|
2019 |
|
% Change |
|||||||||||
Sales volume (lbs) |
|
11,827 |
|
|
12,047 |
|
|
(1.8 |
)% |
|
45,175 |
|
|
43,983 |
|
|
2.7 |
% |
||||
Net sales |
|
$ |
35,843 |
|
|
$ |
34,494 |
|
|
3.9 |
% |
|
$ |
139,288 |
|
|
$ |
133,807 |
|
|
4.1 |
% |
Ongoing operations: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
EBITDA |
|
$ |
11,179 |
|
|
$ |
10,681 |
|
|
4.7 |
% |
|
$ |
45,107 |
|
|
$ |
41,133 |
|
|
9.7 |
% |
Depreciation & amortization |
|
(1,894 |
) |
|
(1,480 |
) |
|
(28.0 |
)% |
|
(6,762 |
) |
|
(5,860 |
) |
|
(15.4 |
)% |
||||
EBIT* |
|
$ |
9,285 |
|
|
$ |
9,201 |
|
|
0.9 |
% |
|
$ |
38,345 |
|
|
$ |
35,273 |
|
|
8.7 |
% |
Capital expenditures |
|
$ |
1,147 |
|
|
$ |
2,993 |
|
|
|
|
$ |
6,024 |
|
|
$ |
8,567 |
|
|
|
||
* See the attached net sales and EBITDA from ongoing operations by segment statements for a reconciliation of this non-GAAP measure to GAAP. |
Fourth Quarter 2020 Results vs. Fourth Quarter 2019 Results
Net sales in the fourth quarter of 2020 increased by 3.9% versus 2019 primarily due to favorable sales mix in Surface Protection.
EBITDA from ongoing operations in the fourth quarter of 2020 increased by
Full Year 2020 Results vs. Full Year 2019 Results
Net sales increased by 4.1% in 2020 versus 2019 primarily due to higher sales of products in Surface Protection unrelated to customer product transitions (
EBITDA from ongoing operations in 2020 increased by
-
A
$3.2 million increase from Surface Protection, primarily due to sales of products unrelated to the customer product transitions ($8.3 million ), partially offset by lower sales associated with the customer product transitions ($4.5 million ); and -
A
$0.8 million increase fromPottsville Packaging primarily related to higher sales volume and favorable raw materials pricing.
Customer Product Transitions in Surface Protection
The Surface Protection component of
The Company previously reported the risk that a portion of its film products used in surface protection applications will be made obsolete by possible future customer product transitions to less costly alternative processes or materials. These transitions principally relate to one customer. The Company believes that previously reported delays in this customer's transitions were recently resolved by the customer and much of the remaining transitions could occur by the end of 2021. Under this scenario, the Company estimates that the contribution to EBITDA from ongoing operations for
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for
|
Three Months Ended |
|
Favorable/
|
|
Year Ended |
|
Favorable/
|
||||||||||||||
(In thousands, except percentages) |
|
|
|
|
|||||||||||||||||
2020 |
|
2019 |
|
2020 |
|
2019 |
|
||||||||||||||
Sales volume (lbs) |
28,026 |
|
|
25,435 |
|
|
10.2 |
% |
|
113,115 |
|
|
105,276 |
|
|
7.4 |
% |
||||
Net sales |
$ |
34,072 |
|
|
$ |
31,985 |
|
|
6.5 |
% |
|
$ |
134,605 |
|
|
$ |
133,935 |
|
|
0.5 |
% |
Ongoing operations: |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
EBITDA |
$ |
8,051 |
|
|
$ |
4,260 |
|
|
89.0 |
% |
|
$ |
30,645 |
|
|
$ |
14,737 |
|
|
107.9 |
% |
Depreciation & amortization |
(455 |
) |
|
(416 |
) |
|
(9.4 |
)% |
|
(1,761 |
) |
|
(1,517 |
) |
|
(16.1 |
)% |
||||
EBIT* |
$ |
7,596 |
|
|
$ |
3,844 |
|
|
97.6 |
% |
|
$ |
28,884 |
|
|
$ |
13,220 |
|
|
118.5 |
% |
Capital expenditures |
$ |
2,511 |
|
|
$ |
3,174 |
|
|
|
|
$ |
4,959 |
|
|
$ |
8,866 |
|
|
|
||
* See the attached net sales and EBITDA from ongoing operations by segment statements for a reconciliation of this non-GAAP measure to GAAP. |
Fourth Quarter 2020 Results vs. Fourth Quarter 2019 Results
Net sales in the fourth quarter of 2020 increased 6.5% versus the fourth quarter of 2019 primarily due to higher sales volume and favorable product mix, partially offset by lower selling prices from the pass-through of lower resin costs.
Terphane’s EBITDA from ongoing operations in the fourth quarter of 2020 increased by
-
Lower raw material costs, net of lower selling prices (
$1.8 million ), higher sales volume ($1.2 million ), favorable product mix ($0.7 million ) and lower variable costs ($1.1 million ), partially offset by higher fixed costs ($0.4 million ) and higher selling and general administration expenses ($0.4 million ); -
Net favorable foreign currency translation of Real-denominated costs (
$0.2 million ); and -
Higher foreign currency transaction losses of
$0.5 million in the fourth quarter of 2020 compared to the prior year.
Full Year 2020 Results vs. Full Year 2019 Results
Net sales in 2020 increased 0.5% versus 2019 while volume increased 7.4% versus 2019 primarily due to lower selling prices from lower raw material costs and changes in product mix.
Terphane’s EBITDA from ongoing operations in 2020 increased by
-
Lower raw material costs, net of lower selling prices (
$8.9 million ), higher sales volume ($3.3 million ), favorable product mix ($2.2 million ) and lower fixed costs ($1.0 million ), partially offset by higher variable costs ($1.1 million ) and higher selling and general administration expenses ($0.4 million ); -
Net favorable foreign currency translation of Real-denominated costs (
$1.5 million ); -
Foreign currency transaction losses of
$0.5 million in 2020 versus gains of$0.2 million in 2019; and -
A benefit of
$1.2 million in 2020 resulting from the favorable settlement of a dispute related to value-added taxes.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for Terphane are projected to be
Corporate Expenses, Investments, Interest and Taxes
Pension expense was
Interest expense was
The effective tax rate used to compute income taxes for continuing operations in 2020 was 32.8% compared to 18.8% in 2019. The effective tax rate from ongoing operations comparable to the earnings reconciliation table provided in Note (a) of the Notes to Financial Tables in this press release was 21.4% in 2020 and 21.5% in 2019 (see also Note (f) of the Notes to Financial Tables). An explanation of differences between the effective tax rate for income from continuing operations and the
FORWARD-LOOKING AND CAUTIONARY STATEMENTS
Some of the information contained in this press release may constitute “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. When the Company uses the words “believe,” “estimate,” “anticipate,” “appear to,” “expect,” “project,” “plan,” “likely,” “may” and similar expressions, it does so to identify forward-looking statements. Such statements are based on the Company's then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in or implied by these forward-looking statements. In addition, the Company's current projections for its businesses could be materially affected by the highly uncertain impact of COVID-19. As a consequence, the Company's results could differ significantly from its projections, depending on, among other things, the duration of "shelter in place" orders and the ultimate impact of the pandemic on employees, supply chains, customers and the
- loss or gain of sales to significant customers on which the Company's business is highly dependent;
- inability to achieve sales to new customers to replace lost business;
- inability to develop, efficiently manufacture and deliver new products at competitive prices;
- failure of the Company's customers to achieve success or maintain market share;
- failure to protect our intellectual property rights;
-
risks of doing business in countries outside the
U.S. that affect our international operations; - political, economic, and regulatory factors concerning the Company's products;
- uncertain economic conditions in countries in which the Company does business;
- competition from other manufacturers, including manufacturers in lower-cost countries and manufacturers benefiting from government subsidies;
- impact of fluctuations in foreign exchange rates;
- a change in the amount of the Company's underfunded defined benefit pension plan liability;
- an increase in the operating costs incurred by the Company's business units, including, for example, the cost of raw materials and energy;
- inability to successfully identify, complete or integrate strategic acquisitions; failure to realize the expected benefits of such acquisitions and assumption of unanticipated risks in such acquisitions;
- disruption to the Company's manufacturing facilities;
- the impact of public health epidemics on employees, production and the global economy, such as the coronavirus (COVID-19) currently impacting the global economy;
- an information technology system failure or breach;
- volatility and uncertainty of the valuation of the Company's investment in kaléo;
-
the impact of the imposition of tariffs and sanctions on imported aluminum ingot used by
Bonnell Aluminum ; -
the impact of new tariffs, duties or other trade restrictions imposed as a result of rising trade tensions between the
U.S. and other countries; -
the termination of anti-dumping duties on products imported to
Brazil that compete with products produced byFlexible Packaging ; - failure to establish and maintain effective internal control over financial reporting;
and the other factors discussed in the reports Tredegar files with or furnishes to the
Tredegar does not undertake, and expressly disclaims any duty, to update any forward-looking statement made in this press release to reflect any change in management’s expectations or any change in conditions, assumptions or circumstances on which such statements are based, except as required by applicable law.
To the extent that the financial information portion of this press release contains non-GAAP financial measures, it also presents both the most directly comparable financial measures calculated and presented in accordance with GAAP and a quantitative reconciliation of the difference between any such non-GAAP measures and such comparable GAAP financial measures. Reconciliations of non-GAAP financial measures are provided in the Notes to the Financial Tables included with this press release and can also be found within “Presentations” in the “Investors” section of our website, www.tredegar.com.
Tredegar uses its website as a channel of distribution of material company information. Financial information and other material information regarding Tredegar is posted on and assembled in the “Investors” section of its website.
|
||||||||||||||||
Condensed Consolidated Statements of Income |
||||||||||||||||
(In Thousands, Except Per-Share Data) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
|
|
|
|
|
||||||||||||
|
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
|
|
|
|
||||||||||||
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
||||||||
Sales |
|
$ |
192,524 |
|
|
$ |
198,313 |
|
|
$ |
755,290 |
|
|
$ |
826,324 |
|
Other income (expense), net (c)(d) |
|
(3,396 |
) |
|
(137 |
) |
|
(67,294 |
) |
|
28,371 |
|
||||
|
|
189,128 |
|
|
198,176 |
|
|
687,996 |
|
|
854,695 |
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Cost of goods sold (c) |
|
143,755 |
|
|
152,820 |
|
|
558,967 |
|
|
641,140 |
|
||||
Freight |
|
6,464 |
|
|
7,542 |
|
|
25,686 |
|
|
28,980 |
|
||||
Selling, R&D and general expenses (c) |
|
24,927 |
|
|
22,141 |
|
|
92,644 |
|
|
84,491 |
|
||||
Amortization of intangibles (g) |
|
753 |
|
|
8,419 |
|
|
3,017 |
|
|
13,601 |
|
||||
Pension and postretirement benefits |
|
4,019 |
|
|
2,396 |
|
|
14,720 |
|
|
9,642 |
|
||||
Interest expense |
|
989 |
|
|
697 |
|
|
2,587 |
|
|
4,051 |
|
||||
Asset impairments and costs associated with exit and disposal activities, net of adjustments (c) |
|
1,651 |
|
|
176 |
|
|
1,725 |
|
|
784 |
|
||||
|
|
— |
|
|
— |
|
|
13,696 |
|
|
— |
|
||||
|
|
182,558 |
|
|
194,191 |
|
|
713,042 |
|
|
782,689 |
|
||||
Income (loss) from continuing operations before income taxes |
|
6,570 |
|
|
3,985 |
|
|
(25,046 |
) |
|
72,006 |
|
||||
Income tax expense (benefit) |
|
95 |
|
|
2,995 |
|
|
(8,213 |
) |
|
13,545 |
|
||||
Net income (loss) from continuing operations |
|
6,475 |
|
|
990 |
|
|
(16,833 |
) |
|
58,461 |
|
||||
Income (loss) from discontinued operations, net of tax |
|
(5,580 |
) |
|
(4,126 |
) |
|
(58,611 |
) |
|
(10,202 |
) |
||||
Net income (loss) |
|
$ |
895 |
|
|
$ |
(3,136 |
) |
|
$ |
(75,444 |
) |
|
$ |
48,259 |
|
|
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
Basic: |
|
|
|
|
|
|
|
|
||||||||
Continuing operations |
|
$ |
0.19 |
|
|
$ |
0.03 |
|
|
$ |
(0.51 |
) |
|
$ |
1.76 |
|
Discontinued operations |
|
(0.17 |
) |
|
(0.12 |
) |
|
(1.75 |
) |
|
(0.31 |
) |
||||
Basic earnings (loss) per share |
|
$ |
0.02 |
|
|
$ |
(0.09 |
) |
|
$ |
(2.26 |
) |
|
$ |
1.45 |
|
Diluted: |
|
|
|
|
|
|
|
|
||||||||
Continuing operations |
|
$ |
0.19 |
|
|
$ |
0.03 |
|
|
$ |
(0.51 |
) |
|
$ |
1.76 |
|
Discontinued operations |
|
(0.17 |
) |
|
(0.12 |
) |
|
(1.75 |
) |
|
(0.31 |
) |
||||
Diluted earnings (loss) per share |
|
$ |
0.02 |
|
|
$ |
(0.09 |
) |
|
$ |
(2.26 |
) |
|
$ |
1.45 |
|
|
|
|
|
|
|
|
|
|
||||||||
Shares used to compute earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
Basic |
|
33,421 |
|
|
33,278 |
|
|
33,402 |
|
|
33,236 |
|
||||
Diluted |
|
33,485 |
|
|
33,341 |
|
|
33,402 |
|
|
33,258 |
|
|
||||||||||||||||
|
||||||||||||||||
(In Thousands) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
|
|
|
|
|
||||||||||||
|
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
|
|
|
|
||||||||||||
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
||||||||
|
|
|
|
|
|
|
|
|
||||||||
Aluminum Extrusions |
|
$ |
116,145 |
|
|
$ |
124,292 |
|
|
$ |
455,711 |
|
|
$ |
529,602 |
|
|
|
35,843 |
|
|
34,494 |
|
|
139,288 |
|
|
133,807 |
|
||||
|
|
34,072 |
|
|
31,985 |
|
|
134,605 |
|
|
133,935 |
|
||||
Total net sales |
|
186,060 |
|
|
190,771 |
|
|
729,604 |
|
|
797,344 |
|
||||
Add back freight |
|
6,464 |
|
|
7,542 |
|
|
25,686 |
|
|
28,980 |
|
||||
Sales as shown in the Condensed Consolidated Statements of Income |
|
$ |
192,524 |
|
|
$ |
198,313 |
|
|
$ |
755,290 |
|
|
$ |
826,324 |
|
|
|
|
|
|
|
|
|
|
||||||||
EBITDA from Ongoing Operations |
|
|
|
|
|
|
|
|
||||||||
Aluminum Extrusions: |
|
|
|
|
|
|
|
|
||||||||
Ongoing operations: |
|
|
|
|
|
|
|
|
||||||||
EBITDA (b) |
|
$ |
13,641 |
|
|
$ |
14,452 |
|
|
$ |
55,137 |
|
|
$ |
65,683 |
|
Depreciation & amortization (g) |
|
(4,771 |
) |
|
(4,238 |
) |
|
(17,403 |
) |
|
(16,719 |
) |
||||
EBIT (b) |
|
8,870 |
|
|
10,214 |
|
|
37,734 |
|
|
48,964 |
|
||||
Plant shutdowns, asset impairments, restructurings and other (c) |
|
(869 |
) |
|
106 |
|
|
(3,506 |
) |
|
(561 |
) |
||||
|
|
— |
|
|
— |
|
|
(13,696 |
) |
|
— |
|
||||
Trade name accelerated amortization (g) |
|
— |
|
|
(7,530 |
) |
|
— |
|
|
(10,040 |
) |
||||
|
|
|
|
|
|
|
|
|
||||||||
Ongoing operations: |
|
|
|
|
|
|
|
|
||||||||
EBITDA (b) |
|
11,179 |
|
|
10,681 |
|
|
45,107 |
|
|
41,133 |
|
||||
Depreciation & amortization |
|
(1,894 |
) |
|
(1,480 |
) |
|
(6,762 |
) |
|
(5,860 |
) |
||||
EBIT (b) |
|
9,285 |
|
|
9,201 |
|
|
38,345 |
|
|
35,273 |
|
||||
Plant shutdowns, asset impairments, restructurings and other (c) |
|
(1,751 |
) |
|
(178 |
) |
|
(1,974 |
) |
|
(733 |
) |
||||
|
|
|
|
|
|
|
|
|
||||||||
Ongoing operations: |
|
|
|
|
|
|
|
|
||||||||
EBITDA (b) |
|
8,051 |
|
|
4,260 |
|
|
30,645 |
|
|
14,737 |
|
||||
Depreciation & amortization |
|
(455 |
) |
|
(416 |
) |
|
(1,761 |
) |
|
(1,517 |
) |
||||
EBIT (b) |
|
7,596 |
|
|
3,844 |
|
|
28,884 |
|
|
13,220 |
|
||||
Plant shutdowns, asset impairments, restructurings and other (c) |
|
(4 |
) |
|
— |
|
|
(18 |
) |
|
— |
|
||||
Total |
|
23,127 |
|
|
15,657 |
|
|
85,769 |
|
|
86,123 |
|
||||
Interest income |
|
1 |
|
|
41 |
|
|
44 |
|
|
66 |
|
||||
Interest expense |
|
989 |
|
|
697 |
|
|
2,587 |
|
|
4,051 |
|
||||
Gain (loss) on investment in kaléo accounted for under fair value method (d) |
|
100 |
|
|
— |
|
|
(60,900 |
) |
|
28,482 |
|
||||
Loss on sale of Bright View Technologies (i) |
|
(2,299 |
) |
|
— |
|
|
(2,299 |
) |
|
— |
|
||||
Stock option-based compensation costs |
|
394 |
|
|
791 |
|
|
2,161 |
|
|
4,132 |
|
||||
Corporate expenses, net (c) |
|
12,976 |
|
|
10,225 |
|
|
42,912 |
|
|
34,482 |
|
||||
Income (loss) from continuing operations before income taxes |
|
6,570 |
|
|
3,985 |
|
|
(25,046 |
) |
|
72,006 |
|
||||
Income tax expense (benefit) |
|
95 |
|
|
2,995 |
|
|
(8,213 |
) |
|
13,545 |
|
||||
Net income (loss) from continuing operations |
|
6,475 |
|
|
990 |
|
|
(16,833 |
) |
|
58,461 |
|
||||
Income (loss) from discontinued operations, net of tax |
|
(5,580 |
) |
|
(4,126 |
) |
|
(58,611 |
) |
|
(10,202 |
) |
||||
Net income (loss) |
|
$ |
895 |
|
|
$ |
(3,136 |
) |
|
$ |
(75,444 |
) |
|
$ |
48,259 |
|
|
||||||||
Condensed Consolidated Balance Sheets |
||||||||
(In Thousands) |
||||||||
(Unaudited) |
||||||||
|
|
|
|
|
||||
|
|
|
|
|
||||
Assets |
|
|
|
|
||||
Cash & cash equivalents |
|
$ |
11,846 |
|
|
$ |
31,422 |
|
Accounts & other receivables, net |
|
86,327 |
|
|
89,117 |
|
||
Income taxes recoverable |
|
2,807 |
|
|
2,661 |
|
||
Inventories |
|
66,437 |
|
|
64,205 |
|
||
Prepaid expenses & other |
|
19,679 |
|
|
8,333 |
|
||
Current assets of discontinued operations |
|
1,339 |
|
|
37,418 |
|
||
Total current assets |
|
188,435 |
|
|
233,156 |
|
||
Property, plant & equipment, net |
|
166,545 |
|
|
173,556 |
|
||
Right-of-use leased assets |
|
16,037 |
|
|
18,492 |
|
||
Investment in kaléo (cost basis of |
|
34,600 |
|
|
95,500 |
|
||
Identifiable intangible assets, net |
|
18,820 |
|
|
22,636 |
|
||
|
|
67,708 |
|
|
81,404 |
|
||
Deferred income taxes |
|
19,068 |
|
|
12,435 |
|
||
Other assets |
|
3,506 |
|
|
4,628 |
|
||
Non-current assets of discontinued operations |
|
151 |
|
|
70,861 |
|
||
Total assets |
|
$ |
514,870 |
|
|
$ |
712,668 |
|
Liabilities and Shareholders’ Equity |
|
|
|
|
||||
Accounts payable |
|
$ |
89,702 |
|
|
$ |
87,296 |
|
Accrued expenses |
|
40,741 |
|
|
39,465 |
|
||
Lease liability, short-term |
|
2,082 |
|
|
2,427 |
|
||
Income taxes payable |
|
706 |
|
|
— |
|
||
Current liabilities of discontinued operations |
|
7,521 |
|
|
23,280 |
|
||
Total current liabilities |
|
140,752 |
|
|
152,468 |
|
||
Lease liability, long-term |
|
14,949 |
|
|
17,338 |
|
||
Long-term debt |
|
134,000 |
|
|
42,000 |
|
||
Pension and other postretirement benefit obligations, net |
|
110,585 |
|
|
107,446 |
|
||
Deferred income taxes |
|
— |
|
|
11,019 |
|
||
Other non-current liabilities |
|
5,529 |
|
|
5,297 |
|
||
Non-current liabilities of discontinued operations |
|
— |
|
|
351 |
|
||
Shareholders’ equity |
|
109,055 |
|
|
376,749 |
|
||
Total liabilities and shareholders’ equity |
|
$ |
514,870 |
|
|
$ |
712,668 |
|
|
||||||||
Condensed Consolidated Statements of Cash Flows |
||||||||
(In Thousands) |
||||||||
(Unaudited) |
||||||||
|
|
|
||||||
|
|
Year Ended |
||||||
|
|
|
||||||
|
|
2020 |
|
2019 |
||||
Cash flows from operating activities: |
|
|
|
|
||||
Net income (loss) |
|
$ |
(75,444) |
|
|
$ |
48,259 |
|
Adjustments for noncash items: |
|
|
|
|
||||
Depreciation |
|
28,940 |
|
|
30,683 |
|
||
Amortization of intangibles |
|
3,017 |
|
|
13,601 |
|
||
Reduction of right-of-use assets |
|
2,753 |
|
|
2,588 |
|
||
|
|
13,696 |
|
|
— |
|
||
Deferred income taxes |
|
(16,892) |
|
|
5,856 |
|
||
Accrued pension and postretirement benefits |
|
14,720 |
|
|
9,642 |
|
||
Loss (gain) on investment in kaléo accounted for under the fair value method |
|
60,900 |
|
|
(10,900) |
|
||
Loss on sale of divested businesses |
|
52,326 |
|
|
— |
|
||
Gain on sale of assets |
|
— |
|
|
(6,334) |
|
||
Changes in assets and liabilities: |
|
|
|
|
||||
Accounts and other receivables |
|
(335) |
|
|
16,471 |
|
||
Inventories |
|
(4,366) |
|
|
11,315 |
|
||
Income taxes recoverable/payable |
|
1,617 |
|
|
2,644 |
|
||
Prepaid expenses and other |
|
(2,203) |
|
|
795 |
|
||
Accounts payable and accrued expenses |
|
4,045 |
|
|
(2,937) |
|
||
Lease liability |
|
(3,049) |
|
|
(2,723) |
|
||
Pension and postretirement benefit plan contributions |
|
(12,681) |
|
|
(8,614) |
|
||
Other, net |
|
7,329 |
|
|
5,517 |
|
||
Net cash provided by operating activities |
|
74,373 |
|
|
115,863 |
|
||
Cash flows from investing activities: |
|
|
|
|
||||
Capital expenditures |
|
(23,355) |
|
|
(50,864) |
|
||
Proceeds from the sale of businesses |
|
56,236 |
|
|
— |
|
||
Proceeds from the sale of assets and other |
|
— |
|
|
10,936 |
|
||
Net cash provided by (used in) investing activities |
|
32,881 |
|
|
(39,928) |
|
||
Cash flows from financing activities: |
|
|
|
|
||||
Borrowings |
|
162,250 |
|
|
65,500 |
|
||
Debt principal payments |
|
(70,250) |
|
|
(125,000) |
|
||
Dividends paid |
|
(216,049) |
|
|
(15,325) |
|
||
Debt financing costs |
|
(693) |
|
|
(1,817) |
|
||
Repurchase of employee common stock for tax withholdings |
|
(850) |
|
|
(854) |
|
||
Proceeds from exercise of stock options and other |
|
— |
|
|
184 |
|
||
Net cash used in financing activities |
|
(125,592) |
|
|
(77,312) |
|
||
Effect of exchange rate changes on cash |
|
(1,238) |
|
|
(1,598) |
|
||
Increase (decrease) in cash and cash equivalents |
|
(19,576) |
|
|
(2,975) |
|
||
Cash and cash equivalents at beginning of period |
|
31,422 |
|
|
34,397 |
|
||
Cash and cash equivalents at end of period |
|
$ |
11,846 |
|
|
$ |
31,422 |
|
Notes to the Financial Tables (Unaudited) |
|
(a) |
Tredegar’s presentation of net income (loss) and diluted earnings per share from ongoing operations are non-GAAP financial measures that exclude the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges, discontinued operations and other items (which includes unrealized gains and losses for an investment accounted for under the fair value method) which have been presented separately and removed from net income (loss) from continuing operations and diluted earnings per share as reported under GAAP. Net income and diluted earnings (loss) per share from ongoing operations are key financial and analytical measures used by management to gauge the operating performance of Tredegar’s ongoing operations. They are not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) from continuing operations or earnings (loss) per share as defined by GAAP. They exclude items that management believes do not relate to Tredegar’s ongoing operations. A reconciliation to net income (loss) and diluted earnings (loss) per share from ongoing operations for the three months and the years ended |
|
|
Three Months Ended
|
|
Year Ended
|
||||||||||||
(In millions, except per share data) |
|
2020 |
|
2019 |
|
2020 |
|
2019 |
||||||||
Net income (loss) from continuing operations as reported under GAAP |
|
$ |
6.5 |
|
|
$ |
1.0 |
|
|
$ |
(16.8 |
) |
|
$ |
58.5 |
|
After-tax effects of: |
|
|
|
|
|
|
|
|
||||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
1.2 |
|
|
0.1 |
|
|
1.2 |
|
|
0.6 |
|
||||
(Gains) losses from sale of assets and other: |
|
|
|
|
|
|
|
|
||||||||
(Gain) loss associated with the investment in kaléo |
|
(0.1 |
) |
|
— |
|
|
47.6 |
|
|
(23.3 |
) |
||||
Loss on sale of Bright View Technologies |
|
1.8 |
|
|
— |
|
|
1.8 |
|
|
— |
|
||||
Accelerated trade name amortization |
|
— |
|
|
5.8 |
|
|
— |
|
|
7.8 |
|
||||
Other |
|
0.3 |
|
|
3.0 |
|
|
6.5 |
|
|
4.0 |
|
||||
|
|
— |
|
|
— |
|
|
10.5 |
|
|
— |
|
||||
Net income from ongoing operations |
|
$ |
9.7 |
|
|
$ |
9.9 |
|
|
$ |
50.8 |
|
|
$ |
47.6 |
|
|
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) from continuing operations per share as reported under GAAP (diluted) |
|
$ |
0.19 |
|
|
$ |
0.03 |
|
|
$ |
(0.51 |
) |
|
$ |
1.76 |
|
After-tax effects per diluted share of: |
|
|
|
|
|
|
|
|
||||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
0.04 |
|
|
— |
|
|
0.04 |
|
|
0.02 |
|
||||
(Gains) losses from sale of assets and other: |
|
|
|
|
|
|
|
|
||||||||
(Gain) loss associated with the investment in kaléo |
|
— |
|
|
— |
|
|
1.42 |
|
|
(0.72 |
) |
||||
Loss on sale of Bright View Technologies |
|
0.05 |
|
|
— |
|
|
0.05 |
|
|
— |
|
||||
Accelerated trade name amortization |
|
— |
|
|
0.17 |
|
|
— |
|
|
0.23 |
|
||||
Other |
|
0.01 |
|
|
0.10 |
|
|
0.19 |
|
|
0.13 |
|
||||
|
|
— |
|
|
— |
|
|
0.32 |
|
|
— |
|
||||
Earnings per share from ongoing operations (diluted) |
|
$ |
0.29 |
|
|
$ |
0.30 |
|
|
$ |
1.51 |
|
|
$ |
1.42 |
|
Reconciliations of the pre-tax and post-tax balances attributed to net income (loss) are shown in Note (f). |
(b) |
EBITDA (earnings before interest, taxes, depreciation and amortization) from ongoing operations is the key profitability metric used by the Company’s chief operating decision maker to assess segment financial performance. For more business segment information, see Note 5 in the Notes to Financial Statements in the Form 10-K. |
|
EBIT (earnings before interest and taxes) from ongoing operations is a non-GAAP financial measure included in the accompanying tables and the reconciliation of segment financial information to consolidated results for the Company in the net sales and EBITDA from ongoing operations by segment statements. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) as defined by GAAP. EBIT is a widely understood and utilized metric that is meaningful to certain investors. The Company believes that including this financial metric in the reconciliation of management’s performance metric, EBITDA from ongoing operations, provides useful information to those investors that primarily utilize EBIT to analyze the Company’s core operations. |
(c) |
Losses associated with plant shutdowns, asset impairments, restructurings and other items for the three months and the years ended |
|
Three Months Ended
|
Year Ended
|
||||||||||||
(in millions) |
Pre-Tax |
Net of Tax |
|
Pre-Tax |
Net of Tax |
|||||||||
Aluminum Extrusions: |
|
|
|
|
||||||||||
Losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||||
Consulting expenses for ERP feasibility study2 |
$ |
0.1 |
|
$ |
0.1 |
|
$ |
1.3 |
|
$ |
1.0 |
|
||
Environmental charges at |
0.3 |
|
0.3 |
|
0.3 |
|
0.3 |
|
||||||
COVID-19-related expenses2 |
0.5 |
|
0.3 |
|
1.9 |
|
1.4 |
|
||||||
Total for Aluminum Extrusions |
$ |
0.9 |
|
$ |
0.7 |
|
$ |
3.5 |
|
$ |
2.7 |
|
||
|
|
|
|
|
||||||||||
(Gains)/losses associated with plant shutdowns, asset impairments and restructurings: |
|
|
|
|
||||||||||
Surface Protection restructuring costs - severance |
$ |
1.6 |
|
$ |
1.2 |
|
$ |
1.6 |
|
$ |
1.2 |
|
||
Losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||||
COVID-19-related expenses3 |
0.2 |
|
0.1 |
|
0.3 |
|
0.3 |
|
||||||
Total for |
$ |
1.8 |
|
$ |
1.3 |
|
$ |
1.9 |
|
$ |
1.5 |
|
||
Corporate: |
|
|
|
|
||||||||||
Professional fees associated with: internal control over financial reporting; business development activities; and implementation of new accounting guidance2 |
$ |
1.3 |
|
$ |
0.8 |
|
$ |
5.5 |
|
$ |
4.2 |
|
||
Accelerated recognition of stock option-based compensation2 |
— |
|
— |
|
0.1 |
|
0.1 |
|
||||||
Corporate costs associated with the divested Personal Care business2 |
(0.3 |
) |
(0.2 |
) |
0.9 |
|
0.7 |
|
||||||
Allocation of changes in effective state tax rates resulting primarily from the sale of |
— |
|
(1.5 |
) |
— |
|
(1.5 |
) |
||||||
Loss on sale of Bright View Technologies3 |
2.3 |
|
1.8 |
|
2.3 |
|
1.8 |
|
||||||
Write-down of investment in |
0.1 |
|
0.1 |
|
0.4 |
|
0.3 |
|
||||||
|
— |
|
— |
|
— |
|
(0.6 |
) |
||||||
Stock compensation expense associated with the fair value remeasurement of awards granted at the time of the Special Dividend2 |
0.4 |
|
0.3 |
|
0.4 |
|
0.3 |
|
||||||
Total for Corporate |
$ |
3.8 |
|
$ |
1.3 |
|
$ |
9.6 |
|
$ |
5.3 |
|
||
1. Included in “Cost of goods sold” in the condensed consolidated statements of income.
|
||||||||||||||
|
Three Months Ended |
Year Ended
|
|||||||||||
($ in millions) |
Pre-Tax |
Net of Tax |
|
Pre-Tax |
Net of Tax |
||||||||
Aluminum Extrusions: |
|
|
|
|
|||||||||
Losses from sale of assets, investment writedowns and other items: |
|
|
|
|
|||||||||
Wind damage to roof of |
$ |
(0.4 |
) |
$ |
(0.3 |
) |
$ |
(0.1 |
) |
$ |
(0.1 |
) |
|
Environmental charges at |
0.2 |
|
0.2 |
|
0.6 |
|
0.5 |
|
|||||
Total for Aluminum Extrusions |
$ |
(0.2 |
) |
$ |
(0.1 |
) |
$ |
0.5 |
|
$ |
0.4 |
|
|
|
|
|
|
|
|||||||||
Losses associated with plant shutdowns, asset impairments and restructurings: |
|
|
|
|
|||||||||
Write-off of films production line - |
$ |
— |
|
$ |
— |
|
$ |
0.4 |
|
$ |
0.3 |
|
|
Surface Protection restructuring costs - severance |
0.2 |
|
0.1 |
|
0.3 |
|
0.2 |
|
|||||
Total for |
$ |
0.2 |
|
$ |
0.1 |
|
$ |
0.7 |
|
$ |
0.5 |
|
|
Corporate: |
|
|
|
|
|||||||||
Professional fees associated with: internal control over financial reporting; business development activities; and implementation of new accounting guidance2 |
$ |
0.2 |
|
$ |
0.2 |
|
$ |
3.5 |
|
$ |
2.7 |
|
|
Accelerated recognition of stock option-based compensation2 |
1.3 |
|
1.2 |
|
1.3 |
|
1.2 |
|
|||||
Environmental costs not associated with a business unit2 |
0.6 |
|
0.5 |
|
0.6 |
|
0.5 |
|
|||||
Tax adjustment - FIN 48 reserve reversal3 |
— |
|
— |
|
— |
|
(2.0 |
) |
|||||
Total for Corporate |
$ |
2.1 |
|
$ |
1.9 |
|
$ |
5.4 |
|
$ |
2.4 |
|
|
1. Included in “Cost of goods sold” in the condensed consolidated statements of income.
|
(d) |
A pre-tax loss of |
(e) |
In the first quarter of 2020, the operations of Aluminum Extrusions’ |
(f) |
Tredegar’s presentation of net income (loss) from ongoing operations is a non-GAAP financial measure that excludes the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges, discontinued operations and other items (which includes unrealized gains and losses for an investment accounted for under the fair value method), which has been presented separately and removed from net income (loss) as reported under GAAP. Net income (loss) from ongoing operations is a key financial and analytical measure used by management to gauge the operating performance of Tredegar’s ongoing operations. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) as defined by GAAP. It excludes items that the Company believes do not relate to Tredegar’s ongoing operations. |
Reconciliations of the pre-tax and post-tax balances attributed to net income (loss) from ongoing operations for the three and twelve ended |
(In millions) |
Pre-Tax |
|
Taxes Expense (Benefit) |
|
After-Tax |
|
Effective Tax Rate |
|||||||
Three Months Ended |
(a) |
|
(b) |
|
|
|
(b)/(a) |
|||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
6.6 |
|
|
$ |
0.1 |
|
|
$ |
6.5 |
|
|
1.5 |
% |
Losses associated with plant shutdowns, asset impairments and restructurings |
1.6 |
|
|
0.4 |
|
|
1.2 |
|
|
|
||||
(Gains) losses from sale of assets and other |
4.8 |
|
|
2.8 |
|
|
2.0 |
|
|
|
||||
Net income (loss) from ongoing operations |
$ |
13.0 |
|
|
$ |
3.3 |
|
|
$ |
9.7 |
|
|
25.4 |
% |
Three Months Ended |
|
|
|
|
|
|
|
|||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
4.0 |
|
|
$ |
3.0 |
|
|
$ |
1.0 |
|
|
75.0 |
% |
Losses associated with plant shutdowns, asset impairments and restructurings |
0.2 |
|
|
0.1 |
|
|
0.1 |
|
|
|
||||
(Gains) losses from sale of assets and other |
9.7 |
|
|
0.9 |
|
|
8.8 |
|
|
|
||||
Net income (loss) from ongoing operations |
$ |
13.9 |
|
|
$ |
4.0 |
|
|
$ |
9.9 |
|
|
28.8 |
% |
Twelve Months Ended |
|
|
|
|
|
|
|
|||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
(25.0 |
) |
|
$ |
(8.2 |
) |
|
$ |
(16.8 |
) |
|
32.8 |
% |
Losses associated with plant shutdowns, asset impairments and restructurings |
1.6 |
|
|
0.4 |
|
|
1.2 |
|
|
|
||||
(Gains) losses from sale of assets and other |
74.3 |
|
|
18.4 |
|
|
55.9 |
|
|
|
||||
|
13.7 |
|
|
3.2 |
|
|
10.5 |
|
|
|
||||
Net income (loss) from ongoing operations |
$ |
64.6 |
|
|
$ |
13.8 |
|
|
$ |
50.8 |
|
|
21.4 |
% |
Twelve Months Ended |
|
|
|
|
|
|
|
|||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
72.0 |
|
|
$ |
13.5 |
|
|
$ |
58.5 |
|
|
18.8 |
% |
Losses associated with plant shutdowns, asset impairments and restructurings |
0.8 |
|
|
0.2 |
|
|
0.6 |
|
|
|
||||
(Gains) losses from sale of assets and other |
(12.2 |
) |
|
(0.7 |
) |
|
(11.5 |
) |
|
|
||||
Net income (loss) from ongoing operations |
$ |
60.6 |
|
|
$ |
13.0 |
|
|
$ |
47.6 |
|
|
21.5 |
% |
(g) |
On |
(in millions) |
Three Months Ended |
Year Ended
|
||||
|
$ |
3.6 |
|
$ |
4.8 |
|
Futura - accelerated |
3.9 |
|
5.2 |
|
||
Futura - ongoing1 |
0.1 |
|
0.2 |
|
||
Total amortization |
$ |
7.6 |
|
$ |
10.2 |
|
1. Amortization based on original useful life. |
(h) |
Net debt is calculated as follows: |
|
|
|
|
|
||||
(in millions) |
|
2020 |
|
2019 |
||||
Debt |
|
$ |
134.0 |
|
|
$ |
42.0 |
|
Less: Cash and cash equivalents |
|
11.8 |
|
|
31.4 |
|
||
Net debt |
|
$ |
122.2 |
|
|
$ |
10.6 |
|
Net debt is not intended to represent total debt as defined by GAAP. Net debt is utilized by management in evaluating the Company’s financial leverage and equity valuation, and management believes that investors also may find net debt to be helpful for the same purposes. |
|
(i) |
In |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210316006013/en/
neill.bellamy@tredegar.com
Source: